Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability.
Adult
Anorexia Nervosa
/ blood
Blood Glucose
/ metabolism
Fasting
/ blood
Female
Gene Expression
Genetic Loci
Genome-Wide Association Study
Glucose Intolerance
/ blood
Humans
Insulin
/ blood
Insulin Receptor Substrate Proteins
/ blood
Insulin Resistance
/ genetics
Kruppel-Like Transcription Factors
/ blood
Male
Middle Aged
Phenotype
Sex Characteristics
Sex Factors
Waist-Hip Ratio
White People
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
05 01 2021
05 01 2021
Historique:
received:
23
01
2020
accepted:
22
09
2020
entrez:
6
1
2021
pubmed:
7
1
2021
medline:
13
1
2021
Statut:
epublish
Résumé
Differences between sexes contribute to variation in the levels of fasting glucose and insulin. Epidemiological studies established a higher prevalence of impaired fasting glucose in men and impaired glucose tolerance in women, however, the genetic component underlying this phenomenon is not established. We assess sex-dimorphic (73,089/50,404 women and 67,506/47,806 men) and sex-combined (151,188/105,056 individuals) fasting glucose/fasting insulin genetic effects via genome-wide association study meta-analyses in individuals of European descent without diabetes. Here we report sex dimorphism in allelic effects on fasting insulin at IRS1 and ZNF12 loci, the latter showing higher RNA expression in whole blood in women compared to men. We also observe sex-homogeneous effects on fasting glucose at seven novel loci. Fasting insulin in women shows stronger genetic correlations than in men with waist-to-hip ratio and anorexia nervosa. Furthermore, waist-to-hip ratio is causally related to insulin resistance in women, but not in men. These results position dissection of metabolic and glycemic health sex dimorphism as a steppingstone for understanding differences in genetic effects between women and men in related phenotypes.
Identifiants
pubmed: 33402679
doi: 10.1038/s41467-020-19366-9
pii: 10.1038/s41467-020-19366-9
pmc: PMC7785747
doi:
Substances chimiques
Blood Glucose
0
IRS1 protein, human
0
Insulin
0
Insulin Receptor Substrate Proteins
0
Kruppel-Like Transcription Factors
0
ZNF12 protein, human
0
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
24Subventions
Organisme : Medical Research Council
ID : G0600705
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : R01 DK078616
Pays : United States
Organisme : Wellcome Trust
ID : 098381
Pays : United Kingdom
Organisme : NCRR NIH HHS
ID : UL1 RR033176
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100012C
Pays : United States
Organisme : NIMH NIH HHS
ID : RC2 MH089951
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD028138
Pays : United States
Organisme : Wellcome Trust
ID : 083948
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100009I
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85080
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH063706
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00011-1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 217065/Z/19/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL075366
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/1
Pays : United Kingdom
Organisme : Intramural NIH HHS
ID : ZIA HG000024
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR046838
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH081802
Pays : United States
Organisme : NHGRI NIH HHS
ID : N01HG65403
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL036310
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100010C
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR025005
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG015928
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062101
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100008C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL080295
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087679
Pays : United States
Organisme : NIMH NIH HHS
ID : RC2 MH089995
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201500001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005G
Pays : United States
Organisme : British Heart Foundation
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201100008I
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL059367
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087660
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007C
Pays : United States
Organisme : EPA
ID : EP-C-15-001
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01 HC015103
Pays : United States
Organisme : Wellcome Trust
ID : GR069224
Pays : United Kingdom
Organisme : NIMHD NIH HHS
ID : R01 MD009164
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL054464
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG004171
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG020098
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK072193
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100011C
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL086694
Pays : United States
Organisme : Wellcome Trust
ID : 203141/Z/16/Z
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : R01 HG000376
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG008724
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/2
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 085475/B/08/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00007/10
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL087652
Pays : United States
Organisme : Wellcome Trust
ID : 092447/Z/10/Z
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG004402
Pays : United States
Organisme : Wellcome Trust
ID : WT098017
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC85082
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062106
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC55222
Pays : United States
Organisme : Department of Health
ID : NF-SI-0617-10090
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 106130
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : U01 HL054464
Pays : United States
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L020149/1
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC85086
Pays : United States
Organisme : NHLBI NIH HHS
ID : N02 HL64278
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL119443
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK105535
Pays : United States
Organisme : NIDA NIH HHS
ID : R37 DA018673
Pays : United States
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG032098
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK062370
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL105756
Pays : United States
Organisme : NIA NIH HHS
ID : N01AG12100
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH058799
Pays : United States
Organisme : NIA NIH HHS
ID : R37 AG013196
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL054457
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_12015/2
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG028555
Pays : United States
Organisme : NHLBI NIH HHS
ID : U10 HL054481
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK063491
Pays : United States
Organisme : NHGRI NIH HHS
ID : HHSN268200782096C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100006C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85083
Pays : United States
Organisme : Wellcome Trust
ID : 084727/Z/08/Z
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : P30 DK072488
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005I
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL054457
Pays : United States
Organisme : NIA NIH HHS
ID : N01 AG062103
Pays : United States
Organisme : Wellcome Trust
ID : WT205915
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : HHSN268201500001I
Pays : United States
Organisme : NLM NIH HHS
ID : R01 LM010098
Pays : United States
Organisme : NIDDK NIH HHS
ID : K24 DK080140
Pays : United States
Organisme : NIMH NIH HHS
ID : U24 MH068457
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL072515
Pays : United States
Organisme : Biotechnology and Biological Sciences Research Council
ID : G20234
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 201543/B/16/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL080295
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK078616
Pays : United States
Organisme : NCRR NIH HHS
ID : M01 RR016500
Pays : United States
Organisme : Wellcome Trust
ID : 212259
Pays : United Kingdom
Organisme : NIDDK NIH HHS
ID : U01 DK062370
Pays : United States
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0500539
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG020098
Pays : United States
Organisme : Wellcome Trust
ID : 090532/Z/09/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC75150
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG013196
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100009C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC25195
Pays : United States
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R01 DA018673
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH090941
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL054481
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201100007I
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK092127
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : N01AG50002
Pays : United States
Organisme : NIMH NIH HHS
ID : RL1 MH083268
Pays : United States
Organisme : NIDDK NIH HHS
ID : UM1 DK078616
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR055688
Pays : United States
Organisme : Medical Research Council
ID : MC_UU_00006/3
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01HC85079
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01HC85081
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG023629
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL087641
Pays : United States
Organisme : Wellcome Trust
ID : 202802/Z/16/Z
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : R01 AG027058
Pays : United States
Organisme : NHLBI NIH HHS
ID : N01 HC045133
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG010175
Pays : United States
Organisme : NIDA NIH HHS
ID : HHSN271201200022C
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG018728
Pays : United States
Organisme : Wellcome Trust
ID : 085475/Z/08/Z
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : N01 HC035129
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG023629
Pays : United States
Organisme : British Heart Foundation
ID : PG/07/133/24260
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH101814
Pays : United States
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom
Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Références
Faerch, K., Borch-Johnsen, K., Vaag, A., Jorgensen, T. & Witte, D. R. Sex differences in glucose levels: a consequence of physiology or methodological convenience? The Inter99 study. Diabetologia 53, 858–865 (2010).
pubmed: 20182862
doi: 10.1007/s00125-010-1673-4
Perreault, L. et al. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care 31, 1416–1421 (2008).
pubmed: 18356403
pmcid: 2453677
doi: 10.2337/dc07-2390
Rathmann, W., Strassburger, K., Giani, G., Doring, A. & Meisinger, C. Differences in height explain gender differences in the response to the oral glucose tolerance test. Diabet. Med. 25, 1374–1375 (2008).
pubmed: 19046233
Tramunt, B. et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 63, 453–461 (2020).
pubmed: 31754750
doi: 10.1007/s00125-019-05040-3
Kautzky-Willer, A., Harreiter, J. & Pacini, G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr. Rev. 37, 278–316 (2016).
pubmed: 27159875
pmcid: 4890267
doi: 10.1210/er.2015-1137
Marullo, L., El-Sayed Moustafa, J. S. & Prokopenko, I. Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits. Curr. Diabetes Rep. 14, 551 (2014).
doi: 10.1007/s11892-014-0551-8
Horikoshi, M. et al. Discovery and fine-mapping of glycaemic and obesity-related trait loci using high-density imputation. PLoS Genet. 11, e1005230 (2015).
pubmed: 26132169
pmcid: 4488845
doi: 10.1371/journal.pgen.1005230
Randall, J. C. et al. Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet. 9, e1003500 (2013).
pubmed: 23754948
pmcid: 3674993
doi: 10.1371/journal.pgen.1003500
Heid, I. M. et al. Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat. Genet. 42, 949–960 (2010).
pubmed: 20935629
pmcid: 3000924
doi: 10.1038/ng.685
Kilpelainen, T. O. et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat. Genet. 43, 753–760 (2011).
pubmed: 21706003
pmcid: 3262230
doi: 10.1038/ng.866
Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187–196 (2015).
pubmed: 25673412
pmcid: 4338562
doi: 10.1038/nature14132
Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 44, 981–990 (2012).
pubmed: 22885922
pmcid: 3442244
doi: 10.1038/ng.2383
Sandholm, N. et al. Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes. J. Am. Soc. Nephrol. 24, 1537–1543 (2013).
pubmed: 24029427
pmcid: 3785274
doi: 10.1681/ASN.2012111122
Magi, R., Lindgren, C. M. & Morris, A. P. Meta-analysis of sex-specific genome-wide association studies. Genet Epidemiol. 34, 846–853 (2010).
pubmed: 21104887
pmcid: 3410525
doi: 10.1002/gepi.20540
Magi, R. & Morris, A. P. GWAMA: software for genome-wide association meta-analysis. BMC Bioinforma. 11, 288 (2010).
doi: 10.1186/1471-2105-11-288
International HapMap, C. A haplotype map of the human genome. Nature 437, 1299–1320 (2005).
doi: 10.1038/nature04226
Voight, B. F. et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 8, e1002793 (2012).
pubmed: 22876189
pmcid: 3410907
doi: 10.1371/journal.pgen.1002793
Rueger, S., McDaid, A. & Kutalik, Z. Evaluation and application of summary statistic imputation to discover new height-associated loci. PLoS Genet. 14, e1007371 (2018).
pubmed: 29782485
pmcid: 5983877
doi: 10.1371/journal.pgen.1007371
Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466, 707–713 (2010).
pubmed: 20686565
pmcid: 3039276
doi: 10.1038/nature09270
Scott, R. A. et al. An expanded genome-wide association study of type 2. Diabetes Eur. Diabetes 66, 2888–2902 (2017).
Manning, A. K. et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat. Genet. 44, 659 (2012).
pubmed: 22581228
pmcid: 3613127
doi: 10.1038/ng.2274
Scott, R. A. et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat. Genet. 44, 991–1005 (2012).
pubmed: 22885924
pmcid: 3433394
doi: 10.1038/ng.2385
Pulit, S. L. et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 28, 166–174 (2019).
pubmed: 30239722
doi: 10.1093/hmg/ddy327
Replication, D. I. G. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234–244 (2014).
doi: 10.1038/ng.2897
Voight, B. F. et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42, 579–589 (2010).
pubmed: 20581827
pmcid: 3080658
doi: 10.1038/ng.609
Yang, T. T. et al. Role of transcription factor NFAT in glucose and insulin homeostasis. Mol. Cell Biol. 26, 7372–7387 (2006).
pubmed: 16908540
pmcid: 1636854
doi: 10.1128/MCB.00580-06
Pollak, M. The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat. Rev. Cancer 12, 159–169 (2012).
pubmed: 22337149
doi: 10.1038/nrc3215
Ekyalongo, R. C. & Yee, D. Revisiting the IGF-1R as a breast cancer target. npj Precis. Oncol. 1, 14 (2017).
pubmed: 29152592
pmcid: 5687252
doi: 10.1038/s41698-017-0017-y
Schizophrenia Working Group of the Psychiatric Genomics, C. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421–427 (2014).
doi: 10.1038/nature13595
Willer, C. J. et al. Discovery and refinement of loci associated with lipid levels. Nat. Genet. 45, 1274–1283 (2013).
pubmed: 24097068
pmcid: 3838666
doi: 10.1038/ng.2797
International Multiple Sclerosis Genetics, C. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214–219 (2011).
doi: 10.1038/nature10251
Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).
pubmed: 23128233
pmcid: 3491803
doi: 10.1038/nature11582
Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits. Nat. Genet. 44, S1–S3 (2012). 369-75.
doi: 10.1038/ng.2213
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet. 88, 76–82 (2011).
pubmed: 21167468
pmcid: 3014363
doi: 10.1016/j.ajhg.2010.11.011
Fall, T. et al. Age- and sex-specific causal effects of adiposity on cardiovascular risk factors. Diabetes 64, 1841–1852 (2015).
pubmed: 25712996
pmcid: 4407863
doi: 10.2337/db14-0988
Jansen, R. et al. Gene expression in major depressive disorder. Mol. Psychiatry 21, 339–347 (2016).
pubmed: 26008736
doi: 10.1038/mp.2015.57
Min, J. L. et al. Coexpression network analysis in abdominal and gluteal adipose tissue reveals regulatory genetic loci for metabolic syndrome and related phenotypes. PLoS Genet. 8, e1002505 (2012).
pubmed: 22383892
pmcid: 3285582
doi: 10.1371/journal.pgen.1002505
Dimas, A. S. et al. Sex-biased genetic effects on gene regulation in humans. Genome Res. 22, 2368–2375 (2012).
pubmed: 22960374
pmcid: 3514666
doi: 10.1101/gr.134981.111
Gertow, K. et al. Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ. Cardiovasc Genet. 5, 656–665 (2012).
pubmed: 23152477
doi: 10.1161/CIRCGENETICS.112.963660
Fadista, J. et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc. Natl Acad. Sci. USA 111, 13924–13929 (2014).
pubmed: 25201977
pmcid: 4183326
doi: 10.1073/pnas.1402665111
Nica, A. C. et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 7, e1002003 (2011).
pubmed: 21304890
pmcid: 3033383
doi: 10.1371/journal.pgen.1002003
Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
doi: 10.1038/ng.2653
Shimoyama, M. et al. The Rat Genome Database 2015: genomic, phenotypic and environmental variations and disease. Nucleic Acids Res. 43, D743–D750 (2015).
pubmed: 25355511
doi: 10.1093/nar/gku1026
Meyer, M. et al. A high-coverage genome sequence from an archaic Denisovan individual. Science 338, 222–226 (2012).
pubmed: 22936568
pmcid: 3617501
doi: 10.1126/science.1224344
The, S.T.D.C. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 506, 97 (2013).
Goldfine, A. B. et al. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann. Intern Med. 159, 1–12 (2013).
pubmed: 23817699
pmcid: 4128629
doi: 10.7326/0003-4819-159-1-201307020-00003
Warren, M. P. Endocrine manifestations of eating disorders. J. Clin. Endocrinol. Metab. 96, 333–343 (2011).
pubmed: 21159848
doi: 10.1210/jc.2009-2304
Festa, A. et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes 53, 1549–1555 (2004).
pubmed: 15161760
doi: 10.2337/diabetes.53.6.1549
D’Orazio, P. et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin. Chem. 51, 1573–1576 (2005).
pubmed: 16120945
doi: 10.1373/clinchem.2005.051979
Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat. Genet. 42, 105–116 (2010).
pubmed: 20081858
pmcid: 3018764
doi: 10.1038/ng.520
Prokopenko, I. et al. Variants in MTNR1B influence fasting glucose levels. Nat. Genet. 41, 77–81 (2009).
pubmed: 19060907
doi: 10.1038/ng.290
Li, Y., Willer, C., Sanna, S. & Abecasis, G. Genotype imputation. Annu. Rev. Genom. Hum. Genet. 10, 387–406 (2009).
doi: 10.1146/annurev.genom.9.081307.164242
Li, Y., Willer, C. J., Ding, J., Scheet, P. & Abecasis, G. R. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol. 34, 816–834 (2010).
pubmed: 21058334
pmcid: 3175618
doi: 10.1002/gepi.20533
Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
pubmed: 19543373
pmcid: 2689936
doi: 10.1371/journal.pgen.1000529
Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906–913 (2007).
pubmed: 17572673
doi: 10.1038/ng2088
Browning, B. L. & Browning, S. R. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet. 84, 210–223 (2009).
pubmed: 19200528
pmcid: 2668004
doi: 10.1016/j.ajhg.2009.01.005
Genomes Project, C. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
Rüeger, S., McDaid, A. & Kutalik, Z. Improved imputation of summary statistics for admixed populations. https://www.biorxiv.org/content/10.1101/203927v3 (2018).
Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).
pubmed: 11315092
doi: 10.1111/j.0006-341X.1999.00997.x
Zheng, J. et al. LD Hub: a centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272–279 (2017).
pubmed: 27663502
doi: 10.1093/bioinformatics/btw613
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236–1241 (2015).
pubmed: 26414676
pmcid: 4797329
doi: 10.1038/ng.3406
Haycock, P. C. et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am. J. Clin. Nutr. 103, 965–978 (2016).
pubmed: 26961927
pmcid: 4807699
doi: 10.3945/ajcn.115.118216
Pierce, B. L. & Burgess, S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am. J. Epidemiol. 178, 1177–1184 (2013).
pubmed: 23863760
pmcid: 3783091
doi: 10.1093/aje/kwt084
Burgess, S. et al. Guidelines for performing Mendelian randomization investigations. Wellcome Open Res. 4, 186 (2019).
pubmed: 32760811
doi: 10.12688/wellcomeopenres.15555.1
Burgess, S. et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur. J. Epidemiol. 30, 543–552 (2015).
pubmed: 25773750
pmcid: 4516908
doi: 10.1007/s10654-015-0011-z
Zheng, J. et al. Recent developments in mendelian randomization studies. Curr. Epidemiol. Rep. 4, 330–345 (2017).
pubmed: 29226067
pmcid: 5711966
doi: 10.1007/s40471-017-0128-6
Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512–525 (2015).
pubmed: 26050253
pmcid: 4469799
doi: 10.1093/ije/dyv080
Lukowiak, B. et al. Identification and purification of functional human beta-cells by a new specific zinc-fluorescent probe. J. Histochem. Cytochem. 49, 519–528 (2001).
pubmed: 11259455
doi: 10.1177/002215540104900412
Taneera, J. et al. A systems genetics approach identifies genes and pathways for type 2 diabetes in human islets. Cell Metab. 16, 122–134 (2012).
pubmed: 22768844
doi: 10.1016/j.cmet.2012.06.006
Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
pubmed: 19289445
pmcid: 2672628
doi: 10.1093/bioinformatics/btp120
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
pubmed: 19261174
pmcid: 2690996
doi: 10.1186/gb-2009-10-3-r25
Anders, S., Reyes, A. & Huber, W. Detecting differential usage of exons from RNA-seq data. Genome Res. 22, 2008–2017 (2012).
pubmed: 22722343
pmcid: 3460195
doi: 10.1101/gr.133744.111
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
pubmed: 20196867
pmcid: 2864565
doi: 10.1186/gb-2010-11-3-r25
Roberts, A., Pimentel, H., Trapnell, C. & Pachter, L. Identification of novel transcripts in annotated genomes using RNA-Seq. Bioinformatics 27, 2325–2329 (2011).
pubmed: 21697122
doi: 10.1093/bioinformatics/btr355
Harrow, J. et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 22, 1760–1774 (2012).
pubmed: 22955987
pmcid: 3431492
doi: 10.1101/gr.135350.111
Wang, L. et al. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res. 41, e74 (2013).
pubmed: 23335781
pmcid: 3616698
doi: 10.1093/nar/gkt006
Shabalin, A. A. Matrix eQTL: ultra fast eQTL analysis via large matrix operations. Bioinformatics 28, 1353–1358 (2012).
pubmed: 22492648
pmcid: 3348564
doi: 10.1093/bioinformatics/bts163
Delaneau, O., Marchini, J. & Zagury, J. F. A linear complexity phasing method for thousands of genomes. Nat. Methods 9, 179–181 (2012).
doi: 10.1038/nmeth.1785
Dai, M. et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res. 33, e175 (2005).
pubmed: 16284200
pmcid: 1283542
doi: 10.1093/nar/gni179
Irizarry, R. A. et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249–264 (2003).
pubmed: 12925520
doi: 10.1093/biostatistics/4.2.249
Iotchkova, V. et al. Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps. Nat. Genet. 48, 1303–1312 (2016).
pubmed: 27668658
pmcid: 5279872
doi: 10.1038/ng.3668
Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539–1558 (2002).
pubmed: 12111919
doi: 10.1002/sim.1186